NAMPT
Salvage pathway
NAD+ is continuously regenerated from NMN, NR, and niacin. NAMPT is the rate-limiting enzyme that converts nicotinamide to NMN, keeping the pool topped up, the most-studied pathway in NAD+ research.
Research Use Only
Research Use Only · Not for medical or veterinary use
A dinucleotide coenzyme studied for its role in mitochondrial energy production, ageing, and metabolism. Below: the biochemistry of the salvage pathway, how the NAD+/NADH redox pair drives the cell, which enzymes consume the pool, and the questions researchers ask before ordering.
Last reviewed
NAD+ is not an end in itself, it is the currency the cell pays with. The pool is built by the salvage pathway, carries electrons as a redox pair, and is consumed by enzymes that govern ageing and DNA repair. Researchers use the three axes to isolate individual steps in in-vitro work.
NAMPT
Salvage pathway
NAD+ is continuously regenerated from NMN, NR, and niacin. NAMPT is the rate-limiting enzyme that converts nicotinamide to NMN, keeping the pool topped up, the most-studied pathway in NAD+ research.
NAD+/NADH
NAD+/NADH redox pair
NAD+ accepts electrons to become NADH in glycolysis and the citric acid cycle, then releases them in the respiratory chain. The NAD+/NADH ratio reflects mitochondrial energy status in in-vitro models.
SIRT · PARP · CD38
NAD+-consuming enzymes
Sirtuins (SIRT1–7), PARP, and CD38 cleave NAD+ as they act on gene expression, DNA repair, and signalling. CD38 consumes a growing share of the pool with age.
NAD+ research material is used across ageing and longevity research, metabolic research, mitochondrial studies, and analytical-method work. Nadera supplies it for laboratory study only, not for clinical or veterinary use.
Investigate cellular responses, the NAD+/NADH ratio, and mitochondrial function in controlled laboratory environments.
Study the activity of NAD+-dependent enzymes, sirtuins, PARP, and CD38, and how substrate availability affects their kinetics under defined in-vitro conditions.
Examine redox balance, energy production, and metabolic signalling pathways where NAD+ is a cofactor, from glycolysis to the respiratory chain.
Perform analytical tests to measure NAD+ levels, coenzyme stability, and interaction kinetics with relevant assay panels.
Three candidates that feed the same pool, distinguished by where they enter the salvage pathway. Quick reference for materials sections and protocol notes.
| Compound | Role in the salvage pathway | Commonly used in research for |
|---|---|---|
NAD+ | The active coenzyme form | Direct study of redox, sirtuins, PARP, and CD38 |
NMN | Direct precursor (one step from NAD+) | Salvage-pathway and pool-rebuilding studies |
NR | Precursor converted to NMN | Bioavailability and NAD+-boosting research |
Product-level questions about the compound, pen format, and research applications. For shipping, ordering, and compliance answers, see the full FAQ.
NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme present in every cell that drives energy metabolism. It is studied for its role in redox reactions, mitochondrial function, and as a substrate for NAD+-consuming enzymes in in vitro laboratory research. Nadera supplies NAD+ as research reference material only, not for medical, veterinary, or diagnostic use.
NAD+ research material is used in studies of redox balance, mitochondrial energy production, sirtuin and PARP enzyme kinetics, and ageing and metabolic research. Nadera does not supply NAD+ for medical use, clinical investigation, or veterinary application.
NAD+ is the active coenzyme form that the enzymes actually use. NMN is a direct precursor, one step away in the salvage pathway, and NR is converted to NMN before becoming NAD+. The three differ in where they enter the pathway, so they are studied for different questions about pool rebuilding and bioavailability.
Research-grade NAD+ is manufactured and supplied for in vitro laboratory study, not approved for clinical use. Clinical-grade material is produced under GMP for human trials and is not available outside approved clinical contexts. Nadera supplies research-grade material only.
NAD+ is not well absorbed orally, capsules and powders give limited and variable bioavailability. A pre-filled pen bypasses that and delivers a controlled dose directly. Pens arrive pre-filled and stability-tested, removing reconstitution, bacteriostatic water, and dose calculations, and let researchers begin work the day pens arrive.
Pens are available in 500 mg (1,695 kr) and 1000 mg (2,395 kr) sizes, pre-filled and ready to use. Each shipment includes the pen, a cold-chain box with temperature-monitoring insert, a handling insert with storage and use guidance, and lot documentation.
Compound-level reference data (formula, MW, purity) is available for the relevant lot. Contact the research team for a citation block formatted for materials sections.
Cold-chain dispatch from an EU warehouse, no customs. Replacement on any deviation. First-order satisfaction guaranteed.